Drug Pricing And The AOC Effect
Executive Summary
Alexandria Ocasio-Cortez’ social media celebrity gives the first-year Democratic member of Congress an outsize influence – and she is making pharmaceutical industry profits a priority target. But she is also having a unifying effect in rallying Republicans behind industry.
You may also be interested in...
Republicans Push Back Against Rx Pricing Transparency Bills At House Hearing
Pricing transparency legislation requests too much information, Republicans say during hearing in US House Energy and Commerce Subcommittee on Health.
Drug Pricing Hearing Takes A Partisan Turn As Gilead’s O’Day Holds His Own
Republicans took off the gloves at House oversight hearing on PrEP, arguing Democrats are more interested in scoring political points than seeking policy solutions to high drug costs.
Reducing Patents Gets Attention From House Freedom Caucus At Pricing Hearing
House Oversight Committee Ranking Member Jim Jordan suggests that Congress may need to re-evaluate the length of pharma patents and FDA exclusivities.